Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.
We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.
Teligent Regains Compliance with Nasdaq Filing Requirements and Nasdaq Minimum Market Value Rule
BUENA, N.J. , Jan. 22, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jers...Learn More
Teligent, Inc. Announces Third Quarter 2020 Results
BUENA, N.J. , Dec. 31, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey -based specialty generic pha...Learn More
Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
Scheduled to Reconvene on December 16 , 2020 Company Urgently Encourages Stockholders to Vote BUENA, N.J. , Nov. 25, 202...Learn More